基本信息
浏览量:32
职业迁徙
个人简介
As a member of Mayo Clinic's Myeloma, Amyloidosis, Dysproteinemia Group, Martha Q. Lacy, M.D., conducts research in developing new therapeutics for the treatment of plasma cell disorders.
Dr. Lacy's clinical research centers on immunotherapy, stem cell transplant and novel agents to optimize treatment for multiple myeloma, amyloidosis, Waldenstrom's macroglobulinemia and monoclonal gammopathy. She performs clinical trials and collaborates with scientists on translational research to improve outcomes for patients with these disorders.
研究兴趣
论文共 1274 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Rahma Warsame,Yong-hun Kim, Melody Y. Ouk,Kristin C. Mara,Martha Q. Lacy,Sharonne N. Hayes, Zamzam Shalle,Joyce Balls-Berry,Barbara L. Jordan,Felicity T. Enders, Alexandra P. Wolanskyj-Spinner,Robert J. Spinner
Mayo Clinic Proceedingsno. 3 (2024): 424-434
Research squareno. 1 (2024): 1-7
Blood Cancer Journalno. 1 (2024): 1-6
LEUKEMIA (2024)
Leukemiapp.1-3, (2024)
Clinical Lymphoma Myeloma and Leukemiano. 3 (2023): 413-420
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S191-S191
Nadine Abdallah, Paul DiZona,Amanika Kumar,Betsy LaPlant, Terri Menser, Sarah Aug,Megan Weivoda,Joselle Cook,Francis Buadi,Suzanne R. Hayman,Angela Dispenzieri,Martha Lacy,
Blood (2023): 1986
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S180-S180
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn